Fractyl Health (GUTS) Other Non-Current Assets (2023 - 2026)
Fractyl Health (GUTS) reported Other Non-Current Assets of $4.3 million for Q1 2026, up 645.18% year-on-year from $571000.0 in Q1 2025, and up 1162.61% quarter-over-quarter from $337000.0 in Q4 2025.
Fractyl Health (GUTS) has 4 years of Other Non-Current Assets data on file, last reported at $4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 645.18% year-over-year to $4.3 million; the trailing twelve-month figure through Mar 2026 stood at $4.3 million (up 645.18% YoY), and the FY2025 full-year result was $337000.0, down 92.08% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $4.3 million, up from $337000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.5 million in Q4 2023 and bottomed at $337000.0 in Q4 2025.
- A 4-year average of $2.6 million and a median of $3.3 million in 2024 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 92.08% in 2025 and surged 645.18% in 2026, its largest moves.
- Tracing GUTS's Other Non-Current Assets over 4 years: stood at $5.5 million in 2023, then decreased by 23.15% to $4.3 million in 2024, then slumped by 92.08% to $337000.0 in 2025, then soared by 1162.61% to $4.3 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $4.3 million, $337000.0, and $392000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 2.13 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Fractyl Health | 19.24 Mn | 19.24 Mn | - | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.26 Mn |
| Dec 31, 2025 | 337,000.00 |
| Sep 30, 2025 | 392,000.00 |
| Jun 30, 2025 | 458,000.00 |
| Mar 31, 2025 | 571,000.00 |
| Dec 31, 2024 | 4.26 Mn |
| Sep 30, 2024 | 3.23 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.28 Mn |
| Dec 31, 2023 | 5.54 Mn |